Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments.
52W Range
25thpctl
Volume
2.80×avg
Market Cap
10.38MUSD
P/E Ratio
-0.7TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Aprea Therapeutics, Inc.
APRENASDAQ Global Select·USD·Closed
Aprea Therapeutics, Inc.
APRENASDAQ·USD·Closed
$0.84
−2.50%
$0.84
−$0.02 (2.50%)
52W Range
25thpctl
Volume
2.80×avg
Mkt Cap
10.38MUSD
P/E
-0.7TTM
Div Yield
–ann
APRE: Aprea Therapeutics, Inc. Stock Analysis | finqOS
